2013
DOI: 10.1016/j.jprot.2013.01.011
|View full text |Cite
|
Sign up to set email alerts
|

Proteome changes associated with Leishmania donovani promastigote adaptation to oxidative and nitrosative stresses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
48
0
1

Year Published

2014
2014
2021
2021

Publication Types

Select...
4
2

Relationship

2
4

Authors

Journals

citations
Cited by 51 publications
(53 citation statements)
references
References 62 publications
4
48
0
1
Order By: Relevance
“…We analyzed intracellular ROS generation in promastigotes using 2=,7=-dichlorodihydrofluorescein diacetate (H 2 DCFDA) dye. The ROS level for L. donovani promastigotes exposed to the higher dose of 70 M SAG (SAG 70 ) was found to be ϳ1.2-fold higher (P Ͻ 0.05) than that for promastigotes exposed to the lower dose (SAG 40 ). Similarly, for amphotericin B treatment, promastigotes subjected to the higher dose of Amp B (Amp B 0.06 ) showed ϳ1.3-fold-higher (P Ͻ 0.05) ROS accumulation than did promastigotes subjected to the lower dose of Amp B (Amp B 0.03 ).…”
Section: Resultsmentioning
confidence: 93%
See 4 more Smart Citations
“…We analyzed intracellular ROS generation in promastigotes using 2=,7=-dichlorodihydrofluorescein diacetate (H 2 DCFDA) dye. The ROS level for L. donovani promastigotes exposed to the higher dose of 70 M SAG (SAG 70 ) was found to be ϳ1.2-fold higher (P Ͻ 0.05) than that for promastigotes exposed to the lower dose (SAG 40 ). Similarly, for amphotericin B treatment, promastigotes subjected to the higher dose of Amp B (Amp B 0.06 ) showed ϳ1.3-fold-higher (P Ͻ 0.05) ROS accumulation than did promastigotes subjected to the lower dose of Amp B (Amp B 0.03 ).…”
Section: Resultsmentioning
confidence: 93%
“…As results from previous experiments showed that drug-generated ROS are also capable of inducing LdeIF2␣ phosphorylation, we estimated parasite viability under drug pressure in the presence of GSK2606414. The percent viabilities of promastigotes after 48 h of exposure to SAG 40 or SAG 70 were 71% and 59%, respectively, whereas in the presence of GSK, viabilities were 62% and 46%, respectively. Similarly, with exposure to amphotericin B, viz., Amp B 0.03 or Amp B 0.06 , the percent viabilities were 76% and 52%, respectively, which were further decreased significantly in the presence of GSK2606414 to 61% for treatment with Amp B 0.03 plus GSK and to 39% for treatment with Amp B 0.06 plus GSK (Fig.…”
Section: Resultsmentioning
confidence: 94%
See 3 more Smart Citations